Real-time continuous monitoring of antibiotics in critically ill patients

Cornel Medical is leading specialist teams from University College London and the Institute for Bio-Sensing Technology (IBST) at the University of the West of England to develop technology to provide real-time continuous monitoring of antibiotics in critically ill patients.

Application of optical sensing in POCT

Cornel’s MicroEye(R) microdialysis device is a key factor in enabling therapeutic drug monitoring of immunosuppressants drugs to prevent rejection in transplant patients.

July 7, 2020

Cornel Medical invited to join two EU consortia to develop patient monitoring technologies

Cornel Medical has been invited to join two EU consortia of leading clinical, industrial and academic partners developing patient monitoring technologies. EU grant applications have

July 1, 2020

World-changing innovations are just around the corner?

An excellent article in The Times (published Saturday, 27 June, 2020) If biotech transforms our health in the coming decade it will be through the

June 28, 2020

Interested in working with us?

We are are interested in hearing from commercial and academic organisations who would like to explore the benefits of our MicroEye® technology.

Real-time continuous monitoring of antibiotics in critically ill patients

Related articles

Application of optical sensing in POCT

Cornel Medical invited to join two EU consortia to develop patient monitoring technologies

World-changing innovations are just around the corner?

Interested in working with us?